Treace Medical Concepts, Inc.
TMCI
$2.83
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.97% | -9.86% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.97% | -9.86% | |||
| Cost of Revenue | 9.06% | -9.76% | |||
| Gross Profit | 5.18% | -9.88% | |||
| SG&A Expenses | 0.96% | -5.17% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.82% | -5.56% | |||
| Operating Income | 13.54% | -8.93% | |||
| Income Before Tax | 6.38% | -9.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.38% | -9.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.38% | -9.27% | |||
| EBIT | 13.54% | -8.93% | |||
| EBITDA | 17.36% | -9.73% | |||
| EPS Basic | 7.14% | -8.66% | |||
| Normalized Basic EPS | 12.86% | -8.69% | |||
| EPS Diluted | 7.14% | -8.66% | |||
| Normalized Diluted EPS | 12.86% | -8.69% | |||
| Average Basic Shares Outstanding | 0.81% | 0.55% | |||
| Average Diluted Shares Outstanding | 0.81% | 0.55% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||